Inhaled bronchodilators for chronic bronchitis and emphysema

摘要

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) is a major cause of morbidity and mortality throughout the world (Kuebler et al 2008). Since 2005, the Department of Health (DH), the NHS and other UK organisations have been collaborating to identify ways of reducing the prevalence of COPD and improving the health of patients. This process has culminated in the development of a strategy for COPD services in England (DH2010).The strategy highlights the important role of pharmacological therapies in COPD treatment. The article discusses the pharmacology of oral bronchodilators and their role in the management of chronic obstructive pulmonary disease (COPD). Management of acute exacerbations and the importance of follow up and review are considered briefly. The article includes a description of the damage to the airways caused by COPD.